Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
The Effects of Strontium Ranelate on the Risk of Vertebral Fracture in Women with Postmenopausal Osteoporosis
20041.2k citationsChristian Roux, Ego Seeman et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Á. Balogh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Á. Balogh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Á. Balogh more than expected).
This network shows the impact of papers produced by Á. Balogh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Á. Balogh. The network helps show where Á. Balogh may publish in the future.
Co-authorship network of co-authors of Á. Balogh
This figure shows the co-authorship network connecting the top 25 collaborators of Á. Balogh.
A scholar is included among the top collaborators of Á. Balogh based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Á. Balogh. Á. Balogh is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Seeman, Ego, Jean‐Pierre Devogelaer, R. G. Spector, et al.. (2004). Strontium ranelate: The first anti-osteoporotic agent to reduce the risk of vertebral fracture in patients with lumbar osteopenia. Osteoporosis International. 15(6). 507–508.3 indexed citations
Reginster, Jean‐Yves, K Hoszowski, Á. Balogh, et al.. (2003). Strontium ranelate : a new effective antiosteoporotic treatment reducing the incidence of vertebral and non vertebral fractures in postmenopausal women with osteoporosis. Open Repository and Bibliography (University of Liège).2 indexed citations
9.
Reginster, Jean‐Yves, R. Rizzoli, Á. Balogh, et al.. (2003). Strontium ranelate reduces the risk of vertebral fractures in osteoporotic postmenopausal women without prevalent vertebral fracture. Open Repository and Bibliography (University of Liège).2 indexed citations
10.
Hőhn, József, László Varga, Zsolt Simonka, et al.. (2003). A lokális recidíva okai a végbélrák radikális mûtétei után.. SZTE Publicatio Repozitórium (University of Szeged). 47(4). 355–359.
Reginster, Jean‐Yves, T. D. Spector, J Badurski, et al.. (2002). A short-term run-in study can significantly contribute to increasing the quality of long-term osteoporosis trials. The strontium ranelate phase 3 program. Open Repository and Bibliography (University of Liège).13 indexed citations
13.
Reginster, Jean‐Yves, Tim Spector, J Badurski, et al.. (2002). Optimizing patient adherence and persistence in strontium ranelate phase 3 program using a short term run-in study. Open Repository and Bibliography (University of Liège).1 indexed citations
14.
Meunier, Pierre J., C. Roux, S. Ortolani, et al.. (2002). Strontium ranelate reduces the vertebral fracture risk in women with postmenopausal osteoporosis.. Osteoporosis International. 13(6). 521–522.29 indexed citations
Bettembuk, P. & Á. Balogh. (1999). [The effect of a one-year alendronate therapy on postmenopausal osteoporosis. (Results in Hungary of an international multicenter clinical study)].. PubMed. 140(50). 2799–803.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.